Skip to content
Credit reportVerdict and grounds
Made on 22-11-2026 at 01:18
Reference CK-0654897577-20261122

EFRAX

ActivePrivate limited company0654.897.577Floris Verbraekenlei 2, 2930 Brasschaat
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209) · founded in 2016 · 9th largest company by equity in Brasschaat, Manufacturing sector · financial year to 30 September · one director

Sources: the KBO register on 22-11-2026; the National Bank, annual accounts to 30-09-2025 filed on 04-03-2026; the Belgian Official Gazette, latest deed of 08-01-2024.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 155 micro companies in the pharmaceuticals sector (NACE 21) is 0.4%.
Gross margin
€64,423
▼ 9.4% against 2024
Net result
€45,359
▼ 8.1% against 2024
Equity
€438,324
▲ 11.5% against 2024
Cash
€141,984
▲ 1.4% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. EFRAX made a profit in every financial year since 2017.Annual accounts 2017 to 2025 page 2
  2. Equity stands at €438,324, or 75.9% of the balance sheet total of €577,651. The solvency of 75.9% is higher than at 78% of the 89 companies filing micro accounts in pharmaceuticals (NACE 21) in 2025.Annual accounts to 30-09-2025 page 2
  3. Of the €139,327 of debt, €100,000 runs for more than a year.Annual accounts to 30-09-2025, notes page 2
  4. The last five annual accounts came in on time. The accounts to 30-09-2025 were filed 57 days before the end of the term.National Bank, filing of 04-03-2026 page 5

Representation

The sole manager, , represents EFRAX alone.

Articles of association, Belgian Official Gazette of 25-05-2016, deed 16311158

Ownership

The accounts in the micro format list no shareholders. founded EFRAX by deed of 25-05-2016.

Deed of 25-05-2016

EFRAX · 0654.897.577 · credit report of 22-11-2026Page 1 of 6
EFRAX0654.897.577 · report of 22-11-2026

Financial situation

Annual accounts 2021 to 2025, as filed with the National Bank

Gross margin and net resultin euro

202181,168202278,426202375,607202471,110202564,423202155,443202253,654202357,599202449,356202545,359
gross marginnet result

Equity and debtsin euro

20212022202320242025438,324139,327
equitydebts

Cashin euro

202182,9692022114,637202381,9952024139,9962025141,984
on the balance sheet date
Financial year20212022202320242025Trend
Results
Gross margin€81,168€78,426€75,607€71,110€64,423
Operating result€79,611€76,867€73,997€69,276€63,273
Net result€55,443€53,654€57,599€49,356€45,359
Balance sheet at the closing date
Equity€292,356€346,010€343,609€392,965€438,324
Debts€233,125€210,742€187,147€163,561€139,327
Debts due after more than one year€188,351€164,791€141,231€117,671€100,000
Debts due within one year€44,774€45,951€45,916€45,890€39,327
Cash€82,969€114,637€81,995€139,996€141,984
Balance sheet total€525,481€556,752€530,756€556,526€577,651
Ratios
Solvency55.6%62.1%64.7%70.6%75.9%
Liquidity1.982.634.384.975.08

Source: Annual accounts to 30-09-2025, micro format, filed on 04-03-2026 (2026-00049347); Annual accounts to 30-09-2024, micro format, filed on 04-03-2025 (2025-00045784); Annual accounts 2021 to 2023, filed from 08-03-2022 to 11-03-2024 (2022-07500118, 2023-00041302, 2024-00043497).

Debts fell by €24,234 in 2025.

The annual accounts to 30-09-2025 state no amount of overdue tax or social security (RSZ) debts.

EFRAX states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €71,110 to €64,423.

EFRAX · 0654.897.577 · credit report of 22-11-2026Page 2 of 6
EFRAX0654.897.577 · report of 22-11-2026

Board, signature and ownership

Position on 22-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

The sole manager, , represents EFRAX alone.

Articles of association, Belgian Official Gazette of 25-05-2016, deed 16311158

Board

one director in office
Managercurrent term since 14-12-2023
term without a fixed enddeed of 25-05-2016

Ownership and group

Shareholders

The accounts in the micro format list no shareholders. founded EFRAX by deed of 25-05-2016.

Deed of 25-05-2016

Board changes

appointed as successor director.

Gazette, deed 24311490
EFRAX · 0654.897.577 · credit report of 22-11-2026Page 3 of 6
EFRAX0654.897.577 · report of 22-11-2026

Holdings

EFRAX has 1 holding (own accounts to 30-09-2025).

Country Company Equity Result
Belgium 1
BE 24.96% €128,686 result €122,782

Source: List of holdings in its own accounts to 30-09-2025. Every holding stands with its own latest accounts.

EFRAX · 0654.897.577 · credit report of 22-11-2026Page 4 of 6
EFRAX0654.897.577 · report of 22-11-2026

Events and comparison

Every event since the founding, newest first

Annual accounts 2025 filed, 57 days before the deadline.

NBB filing

Annual accounts 2024 filed, 57 days before the deadline.

NBB filing

Annual accounts 2023 filed, 50 days before the deadline.

NBB filing

Highest result from 2017 to 2025. The net result of €57,599 is the highest of those years.

Financial

Annual accounts 2022 filed, 47 days before the deadline.

NBB filing

Annual accounts 2021 filed, 53 days before the deadline.

NBB filing

Annual accounts 2020 filed, 59 days before the deadline.

NBB filing

Equity above €200,000. With a profit in every financial year since 2017, equity grows to €236,913.

Financial

Annual accounts 2019 filed, 58 days before the deadline.

NBB filing

Annual accounts 2018 filed, 56 days before the deadline.

NBB filing

Equity above €150,000. With a profit in every financial year since 2017, equity grows to €167,966.

Financial

Annual accounts 2017 filed, 55 days before the deadline.

NBB filing

Incorporation. Founding capital of €100,000, 1,200 shares. Founded by . appointed as manager. Published on 25-05-2016.

Gazette, deed 16311158

First establishment. Floris Verbraekenlei 2, Brasschaat.

The return on assets of EFRAX, 7.9%, is higher than at 65% of the 84 companies filing micro accounts in pharmaceuticals (NACE 21) in 2025.

Other findings

Peppol

Reachable for e-invoices since 05-12-2025, under 0208:0654897577.

Sanctions lists

EFRAX · 0654.897.577 · credit report of 22-11-2026Page 5 of 6
EFRAX0654.897.577 · report of 22-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units22-11-2026KBO 0654.897.577
National Bank of BelgiumAnnual accounts to 30-09-2025, micro format04-03-20262026-00049347
National Bank of BelgiumAnnual accounts to 30-09-2024, micro format04-03-20252025-00045784
National Bank of BelgiumAnnual accounts 2021 to 202308-03-2022 to 11-03-20242022-07500118, 2023-00041302, 2024-00043497
Belgian Official GazetteBoard08-01-2024deed 24311490
Belgian Official GazetteArticles of association with the signing rule25-05-2016deed 16311158
Peppol DirectoryRegistration for e-invoices05-12-20250208:0654897577
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies21-11-2026bankruptcy model of 21 November 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 21 November 2026, computed on 21-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

The scores and ratios are Checked's own calculations, not a credit decision.

EFRAX · 0654.897.577 · credit report of 22-11-2026Page 6 of 6